Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
350K
-
Shares change
-
+350K
-
Total reported value, excl. options
-
$8.92M
-
Value change
-
+$8.92M
-
Number of buys
-
1
-
Price
-
$25.48
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q2 2020
2 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q2 2020.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 350K shares
of 61M outstanding shares and own 0.57% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (1.23M shares), FRANKLIN RESOURCES INC (350K shares), TRV GP III, LLC (5.84M shares), FMR LLC (5.33M shares), Redmile Group, LLC (3.41M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.84M shares), CHI Advisors LLC (2.31M shares), TRV GP IV, LLC (2.13M shares), FARALLON CAPITAL MANAGEMENT LLC (851K shares), and Cormorant Asset Management, LP (611K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.